77 related articles for article (PubMed ID: 17950577)
1. Fexofenadine downmodulates antigen-presenting ability of murine epidermal Langerhans cells.
Sugita K; Kabashima K; Tokura Y
J Dermatol Sci; 2008 Jan; 49(1):88-91. PubMed ID: 17950577
[No Abstract] [Full Text] [Related]
2. Nadifloxacin downmodulates antigen-presenting functions of epidermal Langerhans cells and keratinocytes.
Murata K; Sugita K; Kobayashi M; Kabashima K; Tokura Y
J Dermatol Sci; 2006 May; 42(2):91-9. PubMed ID: 16431082
[TBL] [Abstract][Full Text] [Related]
3. Anti-allergic drug olopatadine suppresses murine contact hypersensitivity and downmodulates antigen-presenting ability of epidermal Langerhans cells.
Tokura Y; Kobayashi M; Ito T; Takahashi H; Matsubara A; Takigawa M
Cell Immunol; 2003 Jul; 224(1):47-54. PubMed ID: 14572800
[TBL] [Abstract][Full Text] [Related]
4. Skin application of the nonsteroidal anti-inflammatory drug ketoprofen downmodulates the antigen-presenting ability of Langerhans cells in mice.
Atarashi K; Kabashima K; Akiyama K; Tokura Y
Br J Dermatol; 2008 Aug; 159(2):306-13. PubMed ID: 18565185
[TBL] [Abstract][Full Text] [Related]
5. Antihistaminic drug olopatadine downmodulates CCL17/TARC production by keratinocytes and Langerhans cells.
Sugita K; Kobayashi M; Mori T; Kabashima K; Nakamura M; Tokura Y
J Dermatol; 2009 Dec; 36(12):654-7. PubMed ID: 19958451
[No Abstract] [Full Text] [Related]
6. Mechanism of UV-B-induced impairment of the antigen-presenting capacity of murine epidermal cells.
Stingl LA; Sauder DN; Iijima M; Wolff K; Pehamberger H; Stingl G
J Immunol; 1983 Apr; 130(4):1586-91. PubMed ID: 6187815
[No Abstract] [Full Text] [Related]
7. Catecholamines inhibit the antigen-presenting capability of epidermal Langerhans cells.
Seiffert K; Hosoi J; Torii H; Ozawa H; Ding W; Campton K; Wagner JA; Granstein RD
J Immunol; 2002 Jun; 168(12):6128-35. PubMed ID: 12055224
[TBL] [Abstract][Full Text] [Related]
8. Targeting of epidermal Langerhans cells with antigenic proteins: attempts to harness their properties for immunotherapy.
Flacher V; Sparber F; Tripp CH; Romani N; Stoitzner P
Cancer Immunol Immunother; 2009 Jul; 58(7):1137-47. PubMed ID: 18677477
[TBL] [Abstract][Full Text] [Related]
9. IL-16 variability and modulation by antiallergic drugs in a murine experimental allergic rhinitis model.
Akiyama K; Karaki M; Kobayshi R; Dobashi H; Ishida T; Mori N
Int Arch Allergy Immunol; 2009; 149(4):315-22. PubMed ID: 19295235
[TBL] [Abstract][Full Text] [Related]
10. Fexofenadine Suppresses Delayed-Type Hypersensitivity in the Murine Model of Palladium Allergy.
Matsubara R; Kumagai K; Shigematsu H; Kitaura K; Nakasone Y; Suzuki S; Hamada Y; Suzuki R
Int J Mol Sci; 2017 Jun; 18(7):. PubMed ID: 28672829
[TBL] [Abstract][Full Text] [Related]
11. [Influence of aromatic retinoid on epidermal Langerhans cells].
Kobayashi M
Nihon Hifuka Gakkai Zasshi; 1983 Jun; 93(7):763-71. PubMed ID: 6620639
[No Abstract] [Full Text] [Related]
12. Protective effects of cyclooxygenase-2 inhibitors on narrow-band ultraviolet B-irradiated epidermal Ia+ Langerhans cells and Thy-1+ dendritic epidermal T cells in mice.
Wu Y; Tai CL; Wei H; He F; Wang Y; Zhao Y; Chen HD
Photochem Photobiol; 2008; 84(2):484-8. PubMed ID: 18266820
[TBL] [Abstract][Full Text] [Related]
13. Targeting epidermal Langerhans cells by epidermal powder immunization.
Chen D; Payne LG
Cell Res; 2002 Jun; 12(2):97-104. PubMed ID: 12118944
[TBL] [Abstract][Full Text] [Related]
14. Participation of epidermal langerhans cells in human pathology and their potential as targets for drug development: a review of literature.
Ayala-García I; Hernández-Segura AM; Castell-Rodríguez A; Alvarez Pérez SJ; Téllez BH; Ramírez-González MD
Proc West Pharmacol Soc; 2005; 48():13-20. PubMed ID: 16416652
[TBL] [Abstract][Full Text] [Related]
15. Epidermal Langerhans cells--changing views on their function in vivo.
Romani N; Ebner S; Tripp CH; Flacher V; Koch F; Stoitzner P
Immunol Lett; 2006 Aug; 106(2):119-25. PubMed ID: 16828878
[TBL] [Abstract][Full Text] [Related]
16. [Effect of topical antipsoriatic agents on ATPase-positive epidermal Langerhans cells. Animal experiment studies].
Gruner S; Strunk D; Diezel W
Dermatol Monatsschr; 1987; 173(8):436-40. PubMed ID: 2959574
[No Abstract] [Full Text] [Related]
17. Preferential downmodulation of certain chemokines by fexofenadine in human keratinocytes.
Kobayashi M; Tokura Y
J Dermatol Sci; 2005 Apr; 38(1):67-9. PubMed ID: 15795127
[No Abstract] [Full Text] [Related]
18. Sphingosine-1-phosphate receptor type-1 agonism impairs blood dendritic cell chemotaxis and skin dendritic cell migration to lymph nodes under inflammatory conditions.
Gollmann G; Neuwirt H; Tripp CH; Mueller H; Konwalinka G; Heufler C; Romani N; Tiefenthaler M
Int Immunol; 2008 Jul; 20(7):911-23. PubMed ID: 18495625
[TBL] [Abstract][Full Text] [Related]
19. Freshly isolated Langerhans cells negatively regulate naïve T cell activation in response to peptide antigen through cell-to-cell contact.
Imai Y; Hayashi N; Yasuda K; Tsutsui H; Mizutani H; Nakanishi K
J Dermatol Sci; 2008 Jul; 51(1):19-29. PubMed ID: 18367382
[TBL] [Abstract][Full Text] [Related]
20. Analysis of signaling pathways involved in peptidoglycan-induced RANTES production from murine Langerhans cells.
Matsui K; Wirotesangthong M; Nishikawa A
Int Arch Allergy Immunol; 2009; 149(2):167-72. PubMed ID: 19127075
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
